Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventral Tegmental Area | 3 | 2014 | 36 | 1.350 |
Why?
|
| Cocaine | 4 | 2012 | 219 | 1.010 |
Why?
|
| Porifera | 3 | 2015 | 8 | 0.770 |
Why?
|
| Nitrogen | 3 | 2015 | 63 | 0.690 |
Why?
|
| Pyrrolidines | 2 | 2008 | 26 | 0.630 |
Why?
|
| Acclimatization | 2 | 2014 | 20 | 0.580 |
Why?
|
| Colchicine | 1 | 2015 | 15 | 0.540 |
Why?
|
| Neural Inhibition | 2 | 2012 | 47 | 0.530 |
Why?
|
| Stilbenes | 1 | 2015 | 41 | 0.520 |
Why?
|
| Tubulin | 1 | 2015 | 80 | 0.510 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2014 | 13 | 0.510 |
Why?
|
| Photosynthesis | 1 | 2014 | 28 | 0.510 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2014 | 70 | 0.500 |
Why?
|
| Carbon Dioxide | 1 | 2014 | 78 | 0.490 |
Why?
|
| Ion Channels | 1 | 2012 | 69 | 0.440 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2012 | 5 | 0.430 |
Why?
|
| Anthozoa | 2 | 2010 | 24 | 0.430 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2012 | 75 | 0.420 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2012 | 38 | 0.420 |
Why?
|
| Cell Size | 1 | 2012 | 42 | 0.420 |
Why?
|
| Potassium Channels | 1 | 2012 | 73 | 0.410 |
Why?
|
| Glutamic Acid | 1 | 2012 | 115 | 0.400 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2014 | 1534 | 0.390 |
Why?
|
| Motor Activity | 3 | 2012 | 393 | 0.370 |
Why?
|
| Gene Expression | 1 | 2012 | 639 | 0.360 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 756 | 0.320 |
Why?
|
| Siderophores | 2 | 2020 | 9 | 0.300 |
Why?
|
| Amino Acids, Diamino | 1 | 2006 | 3 | 0.300 |
Why?
|
| Imines | 1 | 2006 | 9 | 0.300 |
Why?
|
| Brain | 2 | 2012 | 1268 | 0.290 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2006 | 29 | 0.290 |
Why?
|
| Eukaryota | 1 | 2006 | 20 | 0.290 |
Why?
|
| Phosphates | 1 | 2006 | 49 | 0.290 |
Why?
|
| Nitrates | 1 | 2006 | 35 | 0.290 |
Why?
|
| Seasons | 1 | 2006 | 112 | 0.280 |
Why?
|
| Animals | 14 | 2020 | 14307 | 0.270 |
Why?
|
| Behavior, Animal | 2 | 2006 | 304 | 0.260 |
Why?
|
| Rats | 6 | 2012 | 3261 | 0.250 |
Why?
|
| Waste Disposal, Fluid | 3 | 2008 | 14 | 0.230 |
Why?
|
| Molecular Structure | 4 | 2015 | 467 | 0.230 |
Why?
|
| Enzyme Inhibitors | 2 | 2018 | 396 | 0.230 |
Why?
|
| Patch-Clamp Techniques | 2 | 2014 | 214 | 0.230 |
Why?
|
| Microsatellite Repeats | 1 | 2022 | 51 | 0.220 |
Why?
|
| alpha-Amylases | 2 | 2021 | 6 | 0.210 |
Why?
|
| Genetics, Population | 1 | 2022 | 66 | 0.210 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2015 | 984 | 0.210 |
Why?
|
| Prazosin | 2 | 2014 | 11 | 0.200 |
Why?
|
| Passiflora | 1 | 2021 | 1 | 0.200 |
Why?
|
| Saponins | 1 | 2021 | 5 | 0.200 |
Why?
|
| Triterpenes | 1 | 2021 | 12 | 0.200 |
Why?
|
| Bivalvia | 1 | 2020 | 20 | 0.200 |
Why?
|
| Vibrio | 1 | 2020 | 16 | 0.200 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2014 | 342 | 0.190 |
Why?
|
| Carbon | 2 | 2014 | 95 | 0.190 |
Why?
|
| Clonidine | 2 | 2012 | 47 | 0.180 |
Why?
|
| Male | 9 | 2018 | 18870 | 0.170 |
Why?
|
| Plant Exudates | 1 | 2018 | 1 | 0.160 |
Why?
|
| Physalis | 1 | 2018 | 3 | 0.160 |
Why?
|
| Esters | 1 | 2018 | 28 | 0.160 |
Why?
|
| Sucrose | 1 | 2018 | 27 | 0.160 |
Why?
|
| Impulsive Behavior | 1 | 2018 | 44 | 0.160 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2015 | 107 | 0.150 |
Why?
|
| Fruit | 1 | 2018 | 159 | 0.140 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 520 | 0.140 |
Why?
|
| Phenyl Ethers | 1 | 2015 | 4 | 0.130 |
Why?
|
| Ascomycota | 1 | 2015 | 15 | 0.130 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2014 | 4 | 0.130 |
Why?
|
| Benzophenanthridines | 1 | 2014 | 9 | 0.130 |
Why?
|
| Nitro Compounds | 1 | 2015 | 32 | 0.130 |
Why?
|
| Adrenergic Agents | 1 | 2014 | 8 | 0.130 |
Why?
|
| Oceans and Seas | 1 | 2014 | 14 | 0.130 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2014 | 10 | 0.130 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 32 | 0.130 |
Why?
|
| Potassium Channel Blockers | 1 | 2014 | 30 | 0.130 |
Why?
|
| Phenylephrine | 1 | 2014 | 34 | 0.130 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2014 | 21 | 0.130 |
Why?
|
| Particle Size | 1 | 2015 | 200 | 0.130 |
Why?
|
| Electron Transport | 1 | 2014 | 38 | 0.130 |
Why?
|
| Electric Stimulation | 1 | 2014 | 177 | 0.120 |
Why?
|
| Presynaptic Terminals | 1 | 2014 | 52 | 0.120 |
Why?
|
| Models, Molecular | 2 | 2015 | 751 | 0.120 |
Why?
|
| Species Specificity | 1 | 2014 | 233 | 0.120 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 116 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 117 | 0.120 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 376 | 0.120 |
Why?
|
| Diterpenes | 1 | 2014 | 83 | 0.120 |
Why?
|
| Protein Kinase C | 1 | 2014 | 110 | 0.120 |
Why?
|
| Cell Cycle | 1 | 2015 | 309 | 0.120 |
Why?
|
| Binding Sites | 1 | 2015 | 597 | 0.120 |
Why?
|
| Anemia | 1 | 2013 | 45 | 0.120 |
Why?
|
| Ecosystem | 1 | 2014 | 119 | 0.120 |
Why?
|
| Students | 1 | 2018 | 452 | 0.120 |
Why?
|
| Indoles | 1 | 2014 | 154 | 0.120 |
Why?
|
| Kidney Transplantation | 1 | 2013 | 85 | 0.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2021 | 281 | 0.110 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2012 | 9 | 0.110 |
Why?
|
| Tetrodotoxin | 1 | 2012 | 20 | 0.110 |
Why?
|
| Excitatory Amino Acids | 1 | 2012 | 7 | 0.110 |
Why?
|
| Protein Isoforms | 1 | 2012 | 121 | 0.110 |
Why?
|
| Sodium Channel Blockers | 1 | 2012 | 16 | 0.110 |
Why?
|
| Quinoxalines | 1 | 2012 | 27 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2013 | 206 | 0.110 |
Why?
|
| Locomotion | 1 | 2012 | 91 | 0.110 |
Why?
|
| Depression | 1 | 2018 | 664 | 0.100 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2015 | 78 | 0.100 |
Why?
|
| Listonella | 1 | 2011 | 1 | 0.100 |
Why?
|
| Emulsions | 2 | 2008 | 31 | 0.100 |
Why?
|
| Aluminum Compounds | 2 | 2007 | 8 | 0.100 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 2128 | 0.100 |
Why?
|
| Cell Death | 2 | 2008 | 260 | 0.100 |
Why?
|
| Intestinal Fistula | 1 | 2010 | 4 | 0.090 |
Why?
|
| Anti-HIV Agents | 1 | 2014 | 394 | 0.090 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 17 | 0.090 |
Why?
|
| Immunologic Factors | 1 | 2010 | 44 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1149 | 0.090 |
Why?
|
| Mexico | 2 | 2022 | 223 | 0.090 |
Why?
|
| Crohn Disease | 1 | 2010 | 55 | 0.090 |
Why?
|
| Iron | 1 | 2011 | 204 | 0.090 |
Why?
|
| Environmental Monitoring | 1 | 2010 | 188 | 0.080 |
Why?
|
| Biological Assay | 1 | 2008 | 56 | 0.080 |
Why?
|
| Peptides | 1 | 2011 | 308 | 0.080 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2008 | 11 | 0.080 |
Why?
|
| Chemistry, Organic | 1 | 2007 | 6 | 0.080 |
Why?
|
| Steroids | 1 | 2007 | 43 | 0.070 |
Why?
|
| Idazoxan | 1 | 2006 | 10 | 0.070 |
Why?
|
| Nitrate Reductase | 1 | 2006 | 2 | 0.070 |
Why?
|
| Atlantic Ocean | 1 | 2006 | 3 | 0.070 |
Why?
|
| Carbonic Anhydrases | 1 | 2006 | 6 | 0.070 |
Why?
|
| Arctic Regions | 1 | 2006 | 16 | 0.070 |
Why?
|
| Coloring Agents | 1 | 2006 | 51 | 0.070 |
Why?
|
| Yohimbine | 1 | 2006 | 26 | 0.070 |
Why?
|
| Chlorophyll | 1 | 2006 | 22 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 48 | 0.070 |
Why?
|
| Stereoisomerism | 1 | 2006 | 162 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 229 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2008 | 296 | 0.060 |
Why?
|
| Water Pollutants, Chemical | 1 | 2006 | 158 | 0.060 |
Why?
|
| Humans | 7 | 2022 | 34853 | 0.060 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2002 | 16 | 0.060 |
Why?
|
| Narcotics | 1 | 2002 | 28 | 0.050 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2002 | 49 | 0.050 |
Why?
|
| Gene Frequency | 1 | 2022 | 155 | 0.050 |
Why?
|
| Time Factors | 1 | 2006 | 1681 | 0.050 |
Why?
|
| Testosterone | 1 | 2002 | 181 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 1425 | 0.050 |
Why?
|
| Mice | 1 | 2012 | 5668 | 0.050 |
Why?
|
| Estrogens | 1 | 2002 | 190 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2002 | 213 | 0.050 |
Why?
|
| Seawater | 1 | 2020 | 46 | 0.050 |
Why?
|
| Plant Leaves | 1 | 2021 | 110 | 0.050 |
Why?
|
| Metabolomics | 1 | 2021 | 76 | 0.050 |
Why?
|
| Multigene Family | 1 | 2020 | 105 | 0.050 |
Why?
|
| Genome, Bacterial | 1 | 2020 | 114 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 173 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2018 | 59 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2021 | 250 | 0.040 |
Why?
|
| Kinetics | 2 | 2011 | 650 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 243 | 0.040 |
Why?
|
| Self Concept | 1 | 2018 | 136 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 255 | 0.040 |
Why?
|
| Mutation | 1 | 2020 | 1023 | 0.040 |
Why?
|
| Antarctic Regions | 1 | 2015 | 9 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 894 | 0.030 |
Why?
|
| Neurons | 1 | 2002 | 1130 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2015 | 203 | 0.030 |
Why?
|
| Erythropoietin | 1 | 2013 | 37 | 0.030 |
Why?
|
| Graft Survival | 1 | 2013 | 34 | 0.030 |
Why?
|
| Morbidity | 1 | 2013 | 94 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2013 | 101 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2015 | 147 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 424 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 423 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 570 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 355 | 0.030 |
Why?
|
| Potentiometry | 1 | 2011 | 6 | 0.030 |
Why?
|
| Female | 4 | 2018 | 19873 | 0.030 |
Why?
|
| Fish Diseases | 1 | 2011 | 4 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 2011 | 71 | 0.030 |
Why?
|
| Ferric Compounds | 1 | 2011 | 49 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 68 | 0.020 |
Why?
|
| Costa Rica | 1 | 2010 | 7 | 0.020 |
Why?
|
| Pacific Ocean | 1 | 2010 | 13 | 0.020 |
Why?
|
| Population Density | 1 | 2010 | 19 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 2561 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2011 | 201 | 0.020 |
Why?
|
| HIV-1 | 1 | 2014 | 678 | 0.020 |
Why?
|
| Oils | 1 | 2008 | 6 | 0.020 |
Why?
|
| Aluminum | 1 | 2008 | 34 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 485 | 0.020 |
Why?
|
| Uridine Triphosphate | 1 | 2008 | 6 | 0.020 |
Why?
|
| Fura-2 | 1 | 2008 | 12 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 435 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2008 | 16 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 2008 | 17 | 0.020 |
Why?
|
| Retinal Vessels | 1 | 2008 | 24 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 4012 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2013 | 1961 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 628 | 0.020 |
Why?
|
| Electrochemistry | 1 | 2007 | 34 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 5035 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2007 | 86 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 136 | 0.020 |
Why?
|
| Dimerization | 1 | 2007 | 102 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2007 | 81 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 173 | 0.020 |
Why?
|
| Industrial Waste | 1 | 2006 | 16 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 180 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2008 | 196 | 0.020 |
Why?
|
| Adult | 2 | 2013 | 11034 | 0.020 |
Why?
|
| Cattle | 1 | 2008 | 472 | 0.020 |
Why?
|
| Water | 1 | 2008 | 283 | 0.020 |
Why?
|
| Temperature | 1 | 2006 | 275 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 3414 | 0.020 |
Why?
|
| Calcium | 1 | 2008 | 445 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2008 | 1442 | 0.010 |
Why?
|
| Muscarinic Agonists | 1 | 2002 | 10 | 0.010 |
Why?
|
| Pilocarpine | 1 | 2002 | 8 | 0.010 |
Why?
|
| Kainic Acid | 1 | 2002 | 47 | 0.010 |
Why?
|
| Stereotyped Behavior | 1 | 2002 | 20 | 0.010 |
Why?
|
| Naloxone | 1 | 2002 | 50 | 0.010 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2002 | 47 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2002 | 104 | 0.010 |
Why?
|
| Corticosterone | 1 | 2002 | 73 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 6448 | 0.010 |
Why?
|
| Reaction Time | 1 | 2002 | 130 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2002 | 137 | 0.010 |
Why?
|
| Estradiol | 1 | 2002 | 244 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 9642 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 528 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 1300 | 0.010 |
Why?
|